VTRS was MYL channeled off 14 yet the LL this year
Post# of 22747
Mylan , famously known as the maker of EpiPen, grabbed our attention in the past few weeks in a very negative way. This is because of the sudden increase in the price of EpiPens. Unbelievable, but yes with almost 500% increase since 2007, today the drug- a life-saving treatment for allergic reactions-costs almost $608. And the company fails at providing any valid reason for this jump in price.
Because of all this office of Attorney General Eric Schneiderman launched an antitrust probe of the EipPen contracts. Due to this new issue, Mylan shares are trading in red. Analysts rate this stock ‘Sell’.
Read More: https://investorshangout.com/post/view?id=403...z6eCjL9sJb
I (Znewcar1) do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
I will not and cannot be held liable for any actions you take as a result of anything you read here.